Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care

Antiviral Therapy

Volumn 17, Issue 1, 2012, Pages 1-8

  Sobrino Vegas, Paz ^a   Rodríguez Urrego, Johana ^a   Berenguer, Juan ^b   Caro Murillo, Ana María ^a   Blanco, José Ramón ^c   Viciana, Pompeyo ^d   Moreno, Santiago ^e   Bernardino, Ignacio ^f   Del Amo, Julia ^a  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL SAN PEDRO   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; DELAYED DIAGNOSIS; DISEASE SPECIFIC SURVIVAL; DISEASE TRANSMISSION; EDUCATIONAL STATUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SPAIN; THERAPY DELAY; TREATMENT RESPONSE; TREND STUDY; VIROLOGY; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DELAYED DIAGNOSIS; EDUCATIONAL STATUS; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; RNA, VIRAL; SPAIN; SURVIVAL RATE; VIRAL LOAD;

EID: 84856196581     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1939     Document Type: Article

References (24)

1. Dray-Spira R, Lert F. Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy. AIDS 2003; 17:283-290. (Pubitemid 36223252)
2. Koskenvuo M, Kaprio J, Romo M, Langinvainio H. Incidence and prognosis of ischaemic heart disease with respect to marital status and social class. A national record linkage study. J Epidemiol Community Health 1981; 35:192-196. (Pubitemid 11002781)
3. Vågerö D, Persson G. Cancer survival and social class in Sweden. J Epidemiol Community Health 1987; 41:204-209. (Pubitemid 17130945)
4. Galobardes B, Shaw M, Lawlor DA, Lynch JW, Davey SG. Indicators of socioeconomic position (part 1). J Epidemiol Community Health 2006; 60:7-12. (Pubitemid 43028623)
5. Girardi E, Aloisi MS, Arici C, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004; 36:951-959. (Pubitemid 38944091)
6. Mayben JK, Kramer JR, Kallen MA, Franzini L, Lairson DR, Giordano TP. Predictors of delayed HIV diagnosis in a recently diagnosed cohort. AIDS Patient Care STDS 2007; 21:195-204. (Pubitemid 46608550)
7. Borrell C, Rodriguez-Sanz M, Pasarin MI, et al. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System? Eur J Public Health 2006; 16:601-608. (Pubitemid 44899961)
8. Del Amo J, del Romero J, Barrasa A, et al. Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999. Sex Transm Infect 2002; 78:255-260.
9. Jarrin I, Lumbreras B, Ferreros I, Perez-Hoyos S, Hurtado I, Hernandez-Aguado I. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of CART. Int J Epidemiol 2007; 36:187-194. (Pubitemid 47061596)
10. Joy R, Druyts EF, Brandson EK, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr 2008; 47:500-505. (Pubitemid 351366966)
11. Marí-Dell'Olmo M, Rodriguez-Sanz M, Garcia-Olalla P, et al. Individual and community-level effects in the socioeconomic inequalities of AIDS-related mortality in an urban area of southern Europe. J Epidemiol Community Health 2007; 61:232-240.
12. McFarland W, Chen S, Hsu L, Schwarcz S, Katz M. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. J Acquir Immune Defic Syndr 2003; 33:96-103. (Pubitemid 36547247)
13. Rapiti E, Porta D, Forastiere F, Fusco D, Perucci CA. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy. Epidemiology 2000; 11:496-501. (Pubitemid 30660026)
14. Sánchez E, Regidor E, de la Fuente L, Luquero FJ, de Mateo S. Role of antiretroviral therapy in the reduction of the association between low educational level and AIDS-related mortality. Med Clin (Barc) 2008; 130:133-135. (Pubitemid 351357923)
15. Wood E, Montaner JS, Chan K, et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS 2002; 16:2065-2072. (Pubitemid 35205271)
16. Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007; 46 Suppl 1:S3-S8. (Pubitemid 47312320)
17. Sobrino-Vegas P, Garcia-San Miguel L, Caro-Murillo AM, et al. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to CART and impact on mortality. Curr HIV Res 2009; 7:224-230.
18. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999; 13:1763-1769. (Pubitemid 30015725)
19. Collazos J, Asensi V, Carton JA, Ibarra S. The influence of the patients' educational levels on socioeconomic, clinical, immunological and virological endpoints. AIDS Care 2009; 21:511-519.
20. Caro-Murillo AM, Castilla J, Perez-Hoyos S, et al. Spanish cohort of naive HIV-infected patients (CoRIS): rationale, organization and initial results. Enferm Infecc Microbiol Clin 2007; 25:23-31.
21. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000; 56:645-646. (Pubitemid 30422662)
22. Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G. Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology 2008; 5:13.
23. Goldman DP, Smith JP. Can patient self-management help explain the SES health gradient? Proc Natl Acad Sci U S A 2002; 99:10929-10934.
24. Braga Ceccato MG, Acurcio FA, Vallano A, Comini CC, Crosland G. Assessment of factors associated with patients'comprehension of treatment at the start of antiretroviral therapy. Enferm Infecc Microbiol Clin 2009; 27:7-13.